Related references
Note: Only part of the references are listed.Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23
Nobuaki Ito et al.
CALCIFIED TISSUE INTERNATIONAL (2021)
The impact of non-additive genetic associations on age-related complex diseases
Marta Guindo-Martinez et al.
NATURE COMMUNICATIONS (2021)
Polypeptide N-acetylgalactosaminyltransferase-Associated Phenotypes in Mammals
Kentaro Kato et al.
MOLECULES (2021)
Increased development of radiographic hip osteoarthritis in individuals with high bone mass: a prospective cohort study
April Hartley et al.
ARTHRITIS RESEARCH & THERAPY (2021)
A novel homozygous variant in exon 10 of the GALNT3 gene causing hyperphosphatemic familial tumoral calcinosis in a family from North India
Devi Dayal et al.
INTRACTABLE & RARE DISEASES RESEARCH (2021)
Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease
M. G. Guerra et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis
Celia L. Gregson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3
Matilde de las Rivas et al.
NATURE CHEMICAL BIOLOGY (2020)
Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene
F. Mahjoubi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)
Identification of type 2 diabetes loci in 433,540 East Asian individuals
Cassandra N. Spracklen et al.
NATURE (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Individuals with high bone mass have increased progression of radiographic and clinical features of knee osteoarthritis
A. Hartley et al.
OSTEOARTHRITIS AND CARTILAGE (2020)
The Musculoskeletal Knowledge Portal: Making Omics Data Useful to the Broader Scientific Community
Douglas P. Kiel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Persistence and adherence to parenteral osteoporosis therapies: a systematic review
G. Koller et al.
OSTEOPOROSIS INTERNATIONAL (2020)
The Genetic Architecture of High Bone Mass
Celia L. Gregson et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in GALNT3 Gene: Experience from Southern Turkey
Rabia Miray Kisla Ekinci et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2019)
Genome-wide association study of type 2 diabetes in Africa
Ji Chen et al.
DIABETOLOGIA (2019)
A global overview of pleiotropy and genetic architecture in complex traits
Kyoko Watanabe et al.
NATURE GENETICS (2019)
An atlas of genetic influences on osteoporosis in humans and mice
John A. Morris et al.
NATURE GENETICS (2019)
Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
Emily A. King et al.
PLOS GENETICS (2019)
Hyperphosphatemic Familial Tumoral Calcinosis With Galnt3 Mutation: Transient Response to Anti-Interleukin-1 Treatments
Astrid Dauchez et al.
JBMR PLUS (2019)
Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS)
Harry L. Hebert et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects
Carolina Medina-Gomez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Genome-wide association study of extreme high bone mass: Contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes
Celia L. Gregson et al.
BONE (2018)
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases
Masahiro Kanai et al.
NATURE GENETICS (2018)
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes
Anubha Mahajan et al.
NATURE GENETICS (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes
Silvia Bonas-Guarch et al.
NATURE COMMUNICATIONS (2018)
Causal associations between risk factors and common diseases inferred from GWAS summary data
Zhihong Zhu et al.
NATURE COMMUNICATIONS (2018)
A review of instrumental variable estimators for Mendelian randomization
Stephen Burgess et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2017)
The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases
Markku Laakso et al.
JOURNAL OF LIPID RESEARCH (2017)
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis
John P. Kemp et al.
NATURE GENETICS (2017)
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease
Wei Zhao et al.
NATURE GENETICS (2017)
PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update
Victor Lopez-Ferrando et al.
NUCLEIC ACIDS RESEARCH (2017)
A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization
Jack Bowden et al.
STATISTICS IN MEDICINE (2017)
Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
Jason Flannick et al.
SCIENTIFIC DATA (2017)
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans
Robert A. Scott et al.
DIABETES (2017)
A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes
Josep M. Mercader et al.
DIABETES (2017)
Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass Cases
Celia L. Gregson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
Mary Scott Ramnitz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
The genetic architecture of type 2 diabetes
Christian Fuchsberger et al.
NATURE (2016)
Identification of two novel mutations in the GALNT3 gene in a Chinese family with hyperphosphatemic familial tumoral calcinosis
Lihao Sun et al.
BONE RESEARCH (2016)
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization
L. Masi et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture
Hou-Feng Zheng et al.
NATURE (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci
Kyle J. Gaulton et al.
NATURE GENETICS (2015)
GALNT3 gene mutation-associated chronic recurrent multifocal osteomyelitis and familial hyperphosphatemic familial tumoral calcinosis
D. El Demellawy et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2015)
Hyperphosphatemic familial tumoral calcinosis: Response to acetazolamide and postulated mechanisms
Gal Finer et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature
Silje Rafaelsen et al.
BMC GENETICS (2014)
Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
Amy L. Williams et al.
NATURE (2014)
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility
Anubha Mahajan et al.
NATURE GENETICS (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prevalence of radiographic hip osteoarthritis is increased in high bone mass
S. A. Hardcastle et al.
OSTEOARTHRITIS AND CARTILAGE (2014)
Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes
Maggie C. Y. Ng et al.
PLOS GENETICS (2014)
Short-Rib Polydactyly and Jeune Syndromes Are Caused by Mutations in WDR60
Aideen M. McInerney-Leo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Analysis of Body Composition in Individuals With High Bone Mass Reveals a Marked Increase in Fat Mass in Women But Not Men
Celia L. Gregson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
A Study Assessing the Association of Glycated Hemoglobin A1C (HbA1C) Associated Variants with HbA1C, Chronic Kidney Disease and Diabetic Retinopathy in Populations of Asian Ancestry
Peng Chen et al.
PLOS ONE (2013)
Multicentric Carpotarsal Osteolysis Is Caused by Mutations Clustering in the Amino-Terminal Transcriptional Activation Domain of MAFB
Andreas Zankl et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada et al.
NATURE GENETICS (2012)
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
Andrew P. Morris et al.
NATURE GENETICS (2012)
SIFT web server: predicting effects of amino acid substitutions on proteins
Ngak-Leng Sim et al.
NUCLEIC ACIDS RESEARCH (2012)
'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass
C. L. Gregson et al.
OSTEOPOROSIS INTERNATIONAL (2012)
A Mouse with an N-Ethyl-N-Nitrosourea (ENU) Induced Trp589Arg Galnt3 Mutation Represents a Model for Hyperphosphataemic Familial Tumoural Calcinosis
Christopher T. Esapa et al.
PLOS ONE (2012)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis
Alan Yancovitch et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
Levels of Serotonin, Sclerostin, Bone Turnover Markers as well as Bone Density and Microarchitecture in Patients With High-Bone-Mass Phenotype Due to a Mutation in Lrp5
Morten Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Genome-Wide Association Study Using Extreme Truncate Selection Identifies Novel Genes Affecting Bone Mineral Density and Fracture Risk
Emma L. Duncan et al.
PLOS GENETICS (2011)
Clinical Variability of Familial Tumoral Calcinosis Caused by Novel GALNT3 Mutations
Shoji Ichikawa et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Familial tumoral calcinosis and hyperostosis-hyperphosphataemia syndrome are different manifestations of the same disease: novel missense mutations in GALNT3
Leo Joseph et al.
SKELETAL RADIOLOGY (2010)
Newly discovered mutations in the GALNT3 gene causing autosomal recessive hyperostosis-hyperphosphatemia syndrome
Faysal Gok et al.
ACTA ORTHOPAEDICA (2009)
Population genomics in a disease targeted primary cell model
Elin Grundberg et al.
GENOME RESEARCH (2009)
Familial Tumoral Calcinosis: A Forty-Year Follow-up on One Family
Kelly D. Carmichael et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features
C. E. Dumitrescu et al.
OSTEOPOROSIS INTERNATIONAL (2009)
A novel missense mutation in GALNT3 causing hyperostosis-hyperphosphataemia syndrome
Hannes Olauson et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Two novel GALNT3 mutations in familial tumoral calcinosis
Holly J. Garringer et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling
Wendy Balemans et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis
Anna Maria Barbieri et al.
JOURNAL OF HUMAN GENETICS (2007)
Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations
Shoji Ichikawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025
Russel Burge et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Hyperostosis-hyperphosphatemia syndrome:: A congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23
Yaacov Frishberg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene
Shoji Ichikawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family
MF Campagnoli et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred
Polina Specktor et al.
JOURNAL OF HUMAN GENETICS (2006)
A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis:: Evidence that the disorder is autosomal recessive
S Ichikawa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders
Y Frishberg et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis
O Topaz et al.
NATURE GENETICS (2004)
The natural history of sclerosteosis
H Hamersma et al.
CLINICAL GENETICS (2003)
A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population
K Staehling-Hampton et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
